10-Q: Pineapple Financial Reports Q1 Loss Amid Crypto Volatility

Sentiment:

Quarterly Report


Pineapple Financial Inc. reported a significant net loss of $6.4 million for Q1 2026, primarily driven by a $6.1 million fair value loss on Injective digital assets, raising substantial doubt about its going concern ability.

Delay expectedThe repayment period for the FalconX loan was extended by one month subsequent to the balance-sheet date, indicating a delay in the original repayment schedule.
Capital raiseSubsequent to November 30, 2025, on January 4, 2026, the company completed a $100 million equity financing in connection with the Injective Digital Asset Treasury Initiative, receiving approximately $19.0 million in cash.Management plans to pursue additional capital and financing arrangements to support ongoing operations and strategic initiatives.
Worse than expectedThe net loss for the quarter was $6.4 million, significantly worse than the $0.7 million loss in the prior year.The company reported a substantial working capital deficit of $13.0 million, indicating a deteriorating liquidity position compared to the prior period.A $6.1 million non-cash fair value loss on crypto assets contributed significantly to the increased net loss, highlighting the volatility and risk of this new investment strategy.

Summary

  • The company incurred a net loss of $6,435,085 for the three months ended November 30, 2025, a substantial increase from $656,894 in the prior year period.
  • Loss from operations significantly widened to $6,561,346 compared to $693,515 in the prior year.
  • Total revenue decreased by 5.8% to $721,727 from $766,074 in the comparable prior-year period.
  • A non-cash fair value loss of $6,140,379 on crypto assets was the primary driver of the increased net loss and total expenses.
  • The company reported a working capital deficit of $13,003,160 as of November 30, 2025, up from $682,096 at August 31, 2025.
  • Cash and cash equivalents decreased to $1,479,167 from $2,117,371 at the beginning of the period.
  • Mortgage origination volume increased by 7.8% to $457.1 million, driven by renewal and refinance activity.
  • Subscription revenue grew to $207,746 from $182,180, reflecting increased adoption of the Pineapple Plus platform.
  • Subsequent to the reporting period, on January 4, 2026, the company completed a $100 million equity financing, receiving approximately $19.0 million in cash, and repaid the FalconX loan.
  • The Injective Foundation became the company's largest shareholder subsequent to the reporting period.

Sentiment

Score: 2

Explanation: The company reported a massive net loss, a significant working capital deficit, and explicitly stated 'substantial doubt about the Company's ability to continue as a going concern.' While subsequent events include a capital raise, the reported period's financial performance is severely negative, driven by a large crypto asset loss.

Positives

  • Mortgage origination volume increased by 7.8% to $457.1 million for the three months ended November 30, 2025, indicating growth in core business activity.
  • Subscription revenue increased to $207,746, reflecting continued adoption and usage of the Pineapple Plus technology platform.
  • Selling, general and administrative expenses decreased by 5.4%, advertising and marketing expenses declined by 54.4%, and salaries, wages, and benefits decreased by 62.8%, demonstrating effective cost-containment measures.
  • Subsequent to the reporting period, the company secured approximately $19.0 million in cash from a $100 million equity financing, significantly improving its liquidity position.
  • The FalconX loan, a major current liability of $11.98 million, was repaid subsequent to the reporting period, reducing immediate debt obligations.

Negatives

  • The company reported a substantial net loss of $6,435,085 for the quarter, an increase of 879.62% compared to the prior year's loss of $656,894.
  • A significant non-cash fair value loss of $6,140,379 on crypto assets was recognized, heavily impacting the net loss.
  • Total revenue decreased by 5.8% to $721,727, reflecting softness in mortgage origination activity and changes in revenue mix.
  • The company had an accumulated deficit of $19,831,524 as of November 30, 2025, up from $13,396,439 at August 31, 2025.
  • A working capital deficit of $13,003,160 was reported, indicating current assets are insufficient to cover current liabilities.
  • Cash and cash equivalents decreased by $638,204 during the quarter to $1,479,167.
  • Interest expense and bank charges increased by 51.99% to $265,236 due to higher borrowings, including the FalconX loan.

Risks

  • The company continues to incur significant operating losses and negative operating cash flows, raising substantial doubt about its ability to continue as a going concern.
  • Managements ability to sustain operations depends on realizing assets, managing obligations, and securing additional financial resources, with no assurance these initiatives will be achieved.
  • The company's strategic investment in digital assets introduces significant market-driven valuation risks, as evidenced by the $6.14 million fair value loss on Injective digital assets during the quarter.
  • Global inflationary pressures and higher interest rates have led to a slowdown in real-estate activity, reduced pricing pressures, and lower transaction volumes in the housing market, impacting the company's core business.
  • A material weakness exists in the company's internal control over financial reporting due to limited personnel and segregation of duties within the finance function.

Future Outlook

Management anticipates a gradual recovery in mortgage activity in fiscal 2026, driven by stabilizing interest rates and improving borrower confidence, supported by ongoing platform enhancements and disciplined capital deployment. The company intends to pursue up to $100 million in aggregate investment in Injective digital assets, subject to market conditions and capital availability, believing this initiative complements its long-term vision of integrating innovative financial technologies.

Management Comments

  • Management believes that, excluding the impact of non-cash fair value adjustments related to digital assets, the underlying operating performance of the Company during the quarter benefited from cost reductions, improved operational efficiency, and continued stabilization of core mortgage-related activities.
  • Management believes this initiative (Injective Digital Asset Treasury Initiative) is complementary to the Company's long-term vision of integrating innovative financial technologies into its broader fintech ecosystem.
  • Management believes the Company has sufficient liquidity to meet its operating requirements and obligations for at least the next twelve months, based on current operating plans, expected cash flows, and access to financing arrangements.

Industry Context

The Canadian mortgage market continued to adjust to changes in monetary policy, with the Bank of Canada reducing benchmark interest rates by approximately 50 basis points through September 2025. While these reductions are expected to improve housing affordability and support market recovery, overall mortgage origination volumes remained below pre-2022 levels due to ongoing affordability pressures, constrained housing supply, and lender underwriting discipline. Mortgage renewal and refinance transactions represented an increasing proportion of total industry activity.

Comparison to Industry Standards

  • NA

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Internal Control WeaknessA material weakness continues to exist related to segregation of duties within the finance function, primarily due to the limited number of personnel responsible for financial reporting and related control activities.2025-11-30This weakness could adversely affect the company's ability to record, process, summarize, and report financial information reliably, despite management's belief that financial statements are fairly presented.

Legal Proceedings

  • The company is not currently a party to any legal proceedings that are deemed to be material to its financial condition or results of operations.

Related Party Transactions

  • Voltedge Ltd., an entity associated with the Injective Foundation, provided a guarantee for the FalconX loan facility.
  • The Injective Foundation became the company's largest shareholder subsequent to the reporting period (January 4, 2026) through a private placement.
  • Two directors advanced an aggregate amount of $629,728 to the company, bearing interest at 12% per annum and repayable on demand. This loan, along with accrued interest, was paid in full in January 2026.

Stakeholder Impact

  • Shareholders face significant dilution from the subsequent equity financing and substantial losses from the fair value adjustment of crypto assets, alongside ongoing going concern risks.
  • Employees may experience continued workforce optimization measures, as salaries, wages, and benefits decreased significantly.
  • Customers (mortgage agents/brokers) continue to adopt the Pineapple Plus platform, benefiting from stable subscription revenue and enhanced technology.
  • Creditors, particularly FalconX Bravo Inc. and the directors who provided loans, have seen their debts repaid subsequent to the reporting period, reducing immediate credit risk for these parties.

Next Steps

  • Secure proceeds expected under the Injective Digital Asset Treasury Initiative.
  • Pursue additional capital and financing arrangements to support ongoing operations.
  • Implement further cost-containment and working capital measures.
  • Continue remediation efforts to address the material weakness in internal control over financial reporting, including enhancing review and approval controls and engaging external accounting and internal-control resources.
  • Monitor the impact of interest rate changes on the real-estate sector and related businesses.

Key Dates

DateDescription
2023-07-14Effective date of a 1-for-3.9 reverse stock split.
2023-11-03Company's eligibility under the Government of Canada Scientific Research and Experimental Development (SR&ED) program ceased.
2024-11-14Issuance of 19,133 common shares (post-reverse) at $12.00 per share under Form S-3 Offering.
2025-01-01Start of period for exercise of prefunded warrants.
2025-05-05Completion of a registered public offering under Form S-1, issuing 500,000 common shares (post-reverse) and 500,000 detachable warrants.
2025-05-31End of period for exercise of prefunded warrants.
2025-07-16Effective date of a 20-for-1 reverse stock split of issued and outstanding common shares.
2025-07-16Grant date for 46,437 restricted share units (RSUs) and 73,570 stock options, expiring on July 16, 2035.
2025-07-31Effective date of lease surrender and termination for British Columbia office.
2025-08-21Date of Lease Surrender Agreement with RPMG Holdings Ltd. for British Columbia office.
2025-09-01Start of the three-month reporting period.
2025-09-30Exercise of 5,000 warrants, resulting in issuance of common shares.
2025-11-30End of the quarterly reporting period.
2025-12-01Expected repayment date for unsecured loan agreements with directors after S1 registration statement filing.
2026-01-04Closing date of the $100 million equity financing and private placement, making Injective Foundation the largest shareholder.
2026-01-09Date company received approximately $19.0 million from the Injective Digital Asset Treasury Initiative.
2026-01-20Date the condensed interim consolidated financial statements were authorized for issue by the Board of Directors.
2030-01-01Extended lease expiry date for Ontario head office premises.
2035-07-16Expiry date for stock options granted on July 16, 2025.

Recommendation

strong sell

The company reported a staggering net loss of $6.4 million, a substantial working capital deficit of $13.0 million, and explicitly disclosed 'substantial doubt about the Company's ability to continue as a going concern.' While a significant capital raise occurred subsequent to the reporting period, the reported financial performance for the quarter is severely distressed. The large non-cash loss on crypto assets introduces significant volatility and risk to the company's financial profile. A seasoned investor would view these results as highly alarming, indicating fundamental operational and financial instability. Despite the subsequent capital injection, the underlying issues and the explicit going concern warning warrant a strong sell recommendation, as the risk of further value erosion remains exceptionally high.

Keywords

Fintech, Mortgage Brokerage, Digital Assets, Injective, SEC Filing, 10-Q, Financial Results, Going Concern, Crypto Assets, Canada Real Estate, Pineapple Plus

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.